NIH K23 Grants — Mentored Patient-Oriented Research Career Development Award
Reviewed by Dr. Meng ZhaoLast reviewed June 9, 2026Data refreshed June 9, 2026Editorial standards
Mentored training for clinicians doing patient-oriented research
Funding
Salary support + ~$30K research/year
Duration
3–5 years
Eligibility
Clinicians focused on patient-oriented research
Activity code
K23
What is the NIH K23 grant?
The K23 is the NIH career development award for clinicians doing patient-oriented research — clinical trials, observational studies, behavioral interventions, and other research that directly involves human subjects. Like K08, it provides 75% protected research time and a research allowance for 3–5 years.
Recent K23 awards from NIH RePORTER
Examples of funded K23 projects across the last two fiscal years. The matching-award count comes from the full result set; funding totals, averages, rankings, and examples use the first 500 records returned by NIH RePORTER. Figures reflect a snapshot last refreshed on June 9, 2026.
Example K23 projects from the sample
Pathogen and patient determinants of Candida gut colonization in critically ill patients
5K23AI185174-03Max Adelman · METHODIST HOSPITAL RESEARCH INSTITUTE, TX · $194,036 · awarded Jun 5, 2026 · NIHPROJECT SUMMARY/ABSTRACT This K23 proposal outlines a five-year research and training plan that will accelerate Dr. Max Adelman’s career as an independent physician-scientist with expertise in Candida colonization and infection in critically ill patients. Dr. Adelman is an infectious diseases and critical care clinician whose translational research focuses…
Personalizing Antimicrobial Use in Ventilator-Associated Pneumonia
5K23AI177689-03Owen Albin · UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI · $194,400 · awarded Jun 3, 2026 · NIHCandidate’s Long-Term Career Goals: To become an independent clinical investigator that strengthens ICU antimicrobial stewardship and personalizes antibiotic use in nosocomial pneumonia. Clinical Problems to be Addressed with this project: Ventilator-associated pneumonia (VAP) is common, costly, and a leading cause of morbidity and mortality in hospitalized…
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
5K23DA055695-05Justin Berk · RHODE ISLAND HOSPITAL, RI · $195,696 · awarded Jun 3, 2026 · NIHPROJECT SUMMARY This K23 application proposes novel research in opioid use disorder (OUD) treatment in a correctional healthcare setting and a robust training plan to support the successful transition of the Dr. Justin Berk, MD MPH MBA (PI) to independent clinician-scientist. His background in public health, health management, and clinical medicine creates…
Developing a predictive risk score for pre-diabetes in youth.
5K23DK139457-02Monica Bianco · LURIE CHILDREN'S HOSPITAL OF CHICAGO, IL · $189,172 · awarded Jun 3, 2026 · NIHPROJECT SUMMARY The prevalence of impaired glucose tolerance (IGT) and youth onset type 2 diabetes (YT2D) is increasing. IGT in adolescence is an indicator of increased risk for YT2D. Compared to adults, YT2D is associated with high therapeutic failure rates, decreased response to insulin sensitizers, and rapid progression to diabetes-related complications…
Localization of cerebral epileptiform activity during stereo EEG monitoring
1K23NS142570-01A1Benjamin Cox · UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL · $237,870 · awarded Jun 3, 2026 · NIHApproximately 1/3 of patients with epilepsy are drug-resistant and should be considered for surgery. Successful epilepsy surgery depends on accurate localization of the seizure onset zone (SOZ), often requiring invasive monitoring with stereoelectroencephalography (sEEG). However, sEEG has inherent spatial limitations, and in many cases, imprecise…
Epidemiological assessment of Strongyloides stercoralis in at-risk populations in Texas
1K23AI199607-01Megan Duffey · BAYLOR COLLEGE OF MEDICINE, TX · $191,219 · awarded Jun 3, 2026 · NIHStrongyloidiasis (causative agent Strongyloides stercoralis) is a neglected tropical disease that is often asymptomatic but causes severe morbidity and mortality when the infection becomes disseminated in periods of host immunosuppression. Due to the auto-infective portion of the S. stercoralis lifecycle, infections can persist for decades, long after a…
Virtual Reality Suicidal Decision Exposure: An Experimental Therapeutics Approach to Targeting Suicide Capability Mechanisms
1K23MH137687-01A1Sarah Brown · FLORIDA STATE UNIVERSITY, FL · $179,716 · awarded Jun 1, 2026 · NIHProject Summary/Abstract To curb the rising rates of suicide, interventions that directly target the causal mechanisms for suicidal behaviors (SB; i.e., suicide capability) are needed. Virtual reality (VR) suicidal decision scenarios are a valid and safe proxy for SB among at-risk individuals and have enabled causal examinations of suicide capability…
Combining Brain Stimulation with Computerized Cognitive Training for MCI
5K23AG090691-02Stephanie Aghamoosa · MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC · $210,168 · awarded May 27, 2026 · NIHPROJECT SUMMARY/ABSTRACT The proposed K23 Award will support Dr. Stephanie Aghamoosa, PhD in launching an independent program of research developing non-pharmacological interventions for the secondary prevention of dementia. Dr. Aghamoosa is a clinical neuropsychologist whose long-term career goal is to become a federally-funded investigator conducting…
Examining the influence of sociodemographic and medical factors on plasma p-tau217 performance in at-risk populations
5K23AG084850-03Corey Bolton · VANDERBILT UNIVERSITY MEDICAL CENTER, TN · $183,789 · awarded May 26, 2026 · NIHABSTRACT. Alzheimer’s disease (AD) is a public health crisis that disproportionately affects individuals in the Black community. With recent advances in treatment, the need for early identification of AD pathology has never been greater. Early detection allows for early intervention which may be essential to slowing or stopping the progression of AD prior…
Longitudinal Academic Performance in Children with a History of Neonatal Abstinence Syndrome
5K23DA055096-05Tammy Corr · PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA · $199,669 · awarded May 26, 2026 · NIHProject Summary/Abstract The objectives of this project are to more thoroughly understand the relationship between neonatal abstinence syndrome (NAS) and longitudinal academic performance. NAS is a withdrawal condition due to in utero drug exposure, most commonly opioids. The syndrome affects more than 32,000 newborns annually in the U.S., and its incidence…
Designing and piloting clinic-based health information technology to improve WIC retention
5K23MD020103-02Kelsey Egan · BOSTON MEDICAL CENTER, MA · $166,738 · awarded May 26, 2026 · NIHPROJECT SUMMARY Food insecurity is a significant public health concern and a focus of federal policy and research due to its negative health impacts, including on the physical, behavioral, and developmental health of young children. Food insecurity remains prevalent in the US, with higher rates among Black and Hispanic households and households with…
Identifying individual clinical and environmental predictors of buprenorphine response to inform treatment for opioid use disorder
1K23DA063863-01A1Allen Bailey · MCLEAN HOSPITAL, MA · $194,206 · awarded May 25, 2026 · NIH1 Project Summary/Abstract 2 3 Despite evidence that buprenorphine maintenance is an effective treatment for many individuals with opioid 4 use disorder (OUD), nearly half of patients receiving buprenorphine for OUD either return to illicit opioid use or 5 prematurely discontinue treatment. However, we do not know who is unlikely to respond to buprenorphine…
Funding institutes in the sample
| Institute | Awards | Funding |
|---|---|---|
| NIH | 500 | $89.3M |
Most frequent institutions in the sample
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — 25 awards
- MASSACHUSETTS GENERAL HOSPITAL — 24 awards
- UNIVERSITY OF PENNSYLVANIA — 22 awards
- JOHNS HOPKINS UNIVERSITY — 17 awards
- UNIVERSITY OF MICHIGAN AT ANN ARBOR — 16 awards
- VANDERBILT UNIVERSITY MEDICAL CENTER — 14 awards
- BRIGHAM AND WOMEN'S HOSPITAL — 14 awards
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — 13 awards
Source: NIH RePORTER. Verify any award in the official record by searching its project number. See our data methodology for how this sample is built and its limitations.
Decision guide
Choose K23 when
Choose K23 when your research directly involves human subjects: trials, registries, biobanks, behavioral interventions.
Choose another mechanism when
Choose K08 for primarily lab-based research even if you're a clinician.
Who applies for K23
Clinicians within ~5 years of training completion who plan a research career focused on patient-oriented investigation.
Compare nearby NIH grant mechanisms
Searchers often land on K23 while deciding between adjacent NIH activity codes. Compare scope, NIH staff involvement, budget scale, and applicant stage before choosing a funding opportunity.
Mentored research training for clinician-scientists doing lab/translational research
Postdoc → faculty transition (mentored K99 then independent R00)
Career development for new investigators needing mentored training
Protected time for established clinician-scientists to mentor
For broad grant lookup, use the NIH grant search to find funded examples by activity code, PI, institution, and award year.
Search tips for K23
- K23 awards are useful predictors of clinical trial PIs in early career.
Search NIH grants by activity code
Find K23-funded PIs
K23 funding trends
K23 frequently asked questions
What is the difference between K08 and K23?
K08 = lab research for clinicians. K23 = patient-oriented research for clinicians. Both are 3–5 year mentored awards with 75% effort.
Related NIH grant types
Mentored Clinical Scientist Career Development Award
Mentored research training for clinician-scientists doing lab/translational research
Pathway to Independence Award
Postdoc → faculty transition (mentored K99 then independent R00)
Mentored Research Scientist Career Development Award
Career development for new investigators needing mentored training
Mid-Career Investigator Award in Patient-Oriented Research
Protected time for established clinician-scientists to mentor